Figure 1 shows the hematoxylin and eosin (H&E) staining features (Figure 1A, 1C, 1E, 1G) and expression patterns of MCM2 in serous carcinoma, endometrioid carcinoma, and clear cell carcinoma using the monoclonal antibody BM28. Here, MCM2 is linked to serous adenocarcinoma.